NFKB1 and disease arising from reactivation of latent virus: Besides genetic alterations targeting important regulators of alternative NF-κB activation, latent infection with the Epstein-Barr virus (EBV) induces non-canonical NF-κB signaling by introduction of the latent membrane protein 1 (LMP1) in approximately 40% of HL cases [175,176].